▶ 調査レポート

世界の家族性喘息管理製品市場 2028年:ネブライザー、喘息吸入器&スペーサー、ピークフローメーター、マスク

• 英文タイトル:Global Family Asthma Management Product Market Insights, Forecast to 2028

Global Family Asthma Management Product Market Insights, Forecast to 2028「世界の家族性喘息管理製品市場 2028年:ネブライザー、喘息吸入器&スペーサー、ピークフローメーター、マスク」(市場規模、市場予測)調査レポートです。• レポートコード:QY2207C3828
• 出版社/出版日:QYResearch / 2022年7月11日
• レポート形態:英文、PDF、86ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界の家族性喘息管理製品の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に家族性喘息管理製品の世界市場のxxx%を占める「ネブライザー」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「オンライン」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国の家族性喘息管理製品の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの家族性喘息管理製品市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの家族性喘息管理製品市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

家族性喘息管理製品のグローバル主要メーカーには、Philips、3A Health Care、DeVilbiss Healthcare、Rossmax International Ltd.、CareFusion、Omron、PARI、GF、Allied Healthcare Productsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

家族性喘息管理製品市場は、種類と用途によって区分されます。世界の家族性喘息管理製品市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
ネブライザー、喘息吸入器&スペーサー、ピークフローメーター、マスク

【用途別セグメント】
オンライン、オフライン

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 家族性喘息管理製品製品概要
- 種類別市場(ネブライザー、喘息吸入器&スペーサー、ピークフローメーター、マスク)
- 用途別市場(オンライン、オフライン)
- 調査の目的
・エグゼクティブサマリー
- 世界の家族性喘息管理製品販売量予測2017-2028
- 世界の家族性喘息管理製品売上予測2017-2028
- 家族性喘息管理製品の地域別販売量
- 家族性喘息管理製品の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別家族性喘息管理製品販売量
- 主要メーカー別家族性喘息管理製品売上
- 主要メーカー別家族性喘息管理製品価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(ネブライザー、喘息吸入器&スペーサー、ピークフローメーター、マスク)
- 家族性喘息管理製品の種類別販売量
- 家族性喘息管理製品の種類別売上
- 家族性喘息管理製品の種類別価格
・用途別市場規模(オンライン、オフライン)
- 家族性喘息管理製品の用途別販売量
- 家族性喘息管理製品の用途別売上
- 家族性喘息管理製品の用途別価格
・北米市場
- 北米の家族性喘息管理製品市場規模(種類別、用途別)
- 主要国別の家族性喘息管理製品市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの家族性喘息管理製品市場規模(種類別、用途別)
- 主要国別の家族性喘息管理製品市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の家族性喘息管理製品市場規模(種類別、用途別)
- 主要国別の家族性喘息管理製品市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の家族性喘息管理製品市場規模(種類別、用途別)
- 主要国別の家族性喘息管理製品市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの家族性喘息管理製品市場規模(種類別、用途別)
- 主要国別の家族性喘息管理製品市場規模(トルコ、サウジアラビア)
・企業情報
Philips、3A Health Care、DeVilbiss Healthcare、Rossmax International Ltd.、CareFusion、Omron、PARI、GF、Allied Healthcare Products
・産業チェーン及び販売チャネル分析
- 家族性喘息管理製品の産業チェーン分析
- 家族性喘息管理製品の原材料
- 家族性喘息管理製品の生産プロセス
- 家族性喘息管理製品の販売及びマーケティング
- 家族性喘息管理製品の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 家族性喘息管理製品の産業動向
- 家族性喘息管理製品のマーケットドライバー
- 家族性喘息管理製品の課題
- 家族性喘息管理製品の阻害要因
・主な調査結果

Market Analysis and Insights: Global Family Asthma Management Product Market
Due to the COVID-19 pandemic, the global Family Asthma Management Product market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Nebulizers accounting for % of the Family Asthma Management Product global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Online segment is altered to an % CAGR throughout this forecast period.
China Family Asthma Management Product market size is valued at US$ million in 2021, while the US and Europe Family Asthma Management Product are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Family Asthma Management Product landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Family Asthma Management Product include Philips, 3A Health Care, DeVilbiss Healthcare, Rossmax International Ltd., CareFusion, Omron, PARI, GF and Allied Healthcare Products. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Family Asthma Management Product Scope and Segment
Family Asthma Management Product market is segmented by Type and by Sales channels. Players, stakeholders, and other participants in the global Family Asthma Management Product market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Sales channels for the period 2017-2028.
Segment by Type
Nebulizers
Asthma Inhalers & Spacers
Peak Flow Meters
Masks
Segment by Sales channels
Online
Offline
By Company
Philips
3A Health Care
DeVilbiss Healthcare
Rossmax International Ltd.
CareFusion
Omron
PARI
GF
Allied Healthcare Products
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Family Asthma Management Product Product Introduction
1.2 Market by Type
1.2.1 Global Family Asthma Management Product Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Nebulizers
1.2.3 Asthma Inhalers & Spacers
1.2.4 Peak Flow Meters
1.2.5 Masks
1.3 Market by Sales channels
1.3.1 Global Family Asthma Management Product Market Size Growth Rate by Sales channels, 2017 VS 2021 VS 2028
1.3.2 Online
1.3.3 Offline
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Family Asthma Management Product Sales Estimates and Forecasts 2017-2028
2.2 Global Family Asthma Management Product Revenue Estimates and Forecasts 2017-2028
2.3 Global Family Asthma Management Product Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Family Asthma Management Product Sales by Region
2.4.1 Global Family Asthma Management Product Sales by Region (2017-2022)
2.4.2 Global Sales Family Asthma Management Product by Region (2023-2028)
2.5 Global Family Asthma Management Product Revenue by Region
2.5.1 Global Family Asthma Management Product Revenue by Region (2017-2022)
2.5.2 Global Family Asthma Management Product Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Family Asthma Management Product Sales by Manufacturers
3.1.1 Global Top Family Asthma Management Product Manufacturers by Sales (2017-2022)
3.1.2 Global Family Asthma Management Product Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Family Asthma Management Product in 2021
3.2 Global Family Asthma Management Product Revenue by Manufacturers
3.2.1 Global Family Asthma Management Product Revenue by Manufacturers (2017-2022)
3.2.2 Global Family Asthma Management Product Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Family Asthma Management Product Revenue in 2021
3.3 Global Family Asthma Management Product Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Family Asthma Management Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Family Asthma Management Product Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Family Asthma Management Product Sales by Type
4.1.1 Global Family Asthma Management Product Historical Sales by Type (2017-2022)
4.1.2 Global Family Asthma Management Product Forecasted Sales by Type (2023-2028)
4.1.3 Global Family Asthma Management Product Sales Market Share by Type (2017-2028)
4.2 Global Family Asthma Management Product Revenue by Type
4.2.1 Global Family Asthma Management Product Historical Revenue by Type (2017-2022)
4.2.2 Global Family Asthma Management Product Forecasted Revenue by Type (2023-2028)
4.2.3 Global Family Asthma Management Product Revenue Market Share by Type (2017-2028)
4.3 Global Family Asthma Management Product Price by Type
4.3.1 Global Family Asthma Management Product Price by Type (2017-2022)
4.3.2 Global Family Asthma Management Product Price Forecast by Type (2023-2028)
5 Market Size by Sales channels
5.1 Global Family Asthma Management Product Sales by Sales channels
5.1.1 Global Family Asthma Management Product Historical Sales by Sales channels (2017-2022)
5.1.2 Global Family Asthma Management Product Forecasted Sales by Sales channels (2023-2028)
5.1.3 Global Family Asthma Management Product Sales Market Share by Sales channels (2017-2028)
5.2 Global Family Asthma Management Product Revenue by Sales channels
5.2.1 Global Family Asthma Management Product Historical Revenue by Sales channels (2017-2022)
5.2.2 Global Family Asthma Management Product Forecasted Revenue by Sales channels (2023-2028)
5.2.3 Global Family Asthma Management Product Revenue Market Share by Sales channels (2017-2028)
5.3 Global Family Asthma Management Product Price by Sales channels
5.3.1 Global Family Asthma Management Product Price by Sales channels (2017-2022)
5.3.2 Global Family Asthma Management Product Price Forecast by Sales channels (2023-2028)
6 North America
6.1 North America Family Asthma Management Product Market Size by Type
6.1.1 North America Family Asthma Management Product Sales by Type (2017-2028)
6.1.2 North America Family Asthma Management Product Revenue by Type (2017-2028)
6.2 North America Family Asthma Management Product Market Size by Sales channels
6.2.1 North America Family Asthma Management Product Sales by Sales channels (2017-2028)
6.2.2 North America Family Asthma Management Product Revenue by Sales channels (2017-2028)
6.3 North America Family Asthma Management Product Market Size by Country
6.3.1 North America Family Asthma Management Product Sales by Country (2017-2028)
6.3.2 North America Family Asthma Management Product Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Family Asthma Management Product Market Size by Type
7.1.1 Europe Family Asthma Management Product Sales by Type (2017-2028)
7.1.2 Europe Family Asthma Management Product Revenue by Type (2017-2028)
7.2 Europe Family Asthma Management Product Market Size by Sales channels
7.2.1 Europe Family Asthma Management Product Sales by Sales channels (2017-2028)
7.2.2 Europe Family Asthma Management Product Revenue by Sales channels (2017-2028)
7.3 Europe Family Asthma Management Product Market Size by Country
7.3.1 Europe Family Asthma Management Product Sales by Country (2017-2028)
7.3.2 Europe Family Asthma Management Product Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Family Asthma Management Product Market Size by Type
8.1.1 Asia Pacific Family Asthma Management Product Sales by Type (2017-2028)
8.1.2 Asia Pacific Family Asthma Management Product Revenue by Type (2017-2028)
8.2 Asia Pacific Family Asthma Management Product Market Size by Sales channels
8.2.1 Asia Pacific Family Asthma Management Product Sales by Sales channels (2017-2028)
8.2.2 Asia Pacific Family Asthma Management Product Revenue by Sales channels (2017-2028)
8.3 Asia Pacific Family Asthma Management Product Market Size by Region
8.3.1 Asia Pacific Family Asthma Management Product Sales by Region (2017-2028)
8.3.2 Asia Pacific Family Asthma Management Product Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Family Asthma Management Product Market Size by Type
9.1.1 Latin America Family Asthma Management Product Sales by Type (2017-2028)
9.1.2 Latin America Family Asthma Management Product Revenue by Type (2017-2028)
9.2 Latin America Family Asthma Management Product Market Size by Sales channels
9.2.1 Latin America Family Asthma Management Product Sales by Sales channels (2017-2028)
9.2.2 Latin America Family Asthma Management Product Revenue by Sales channels (2017-2028)
9.3 Latin America Family Asthma Management Product Market Size by Country
9.3.1 Latin America Family Asthma Management Product Sales by Country (2017-2028)
9.3.2 Latin America Family Asthma Management Product Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Family Asthma Management Product Market Size by Type
10.1.1 Middle East and Africa Family Asthma Management Product Sales by Type (2017-2028)
10.1.2 Middle East and Africa Family Asthma Management Product Revenue by Type (2017-2028)
10.2 Middle East and Africa Family Asthma Management Product Market Size by Sales channels
10.2.1 Middle East and Africa Family Asthma Management Product Sales by Sales channels (2017-2028)
10.2.2 Middle East and Africa Family Asthma Management Product Revenue by Sales channels (2017-2028)
10.3 Middle East and Africa Family Asthma Management Product Market Size by Country
10.3.1 Middle East and Africa Family Asthma Management Product Sales by Country (2017-2028)
10.3.2 Middle East and Africa Family Asthma Management Product Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Philips
11.1.1 Philips Corporation Information
11.1.2 Philips Overview
11.1.3 Philips Family Asthma Management Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Philips Family Asthma Management Product Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Philips Recent Developments
11.2 3A Health Care
11.2.1 3A Health Care Corporation Information
11.2.2 3A Health Care Overview
11.2.3 3A Health Care Family Asthma Management Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 3A Health Care Family Asthma Management Product Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 3A Health Care Recent Developments
11.3 DeVilbiss Healthcare
11.3.1 DeVilbiss Healthcare Corporation Information
11.3.2 DeVilbiss Healthcare Overview
11.3.3 DeVilbiss Healthcare Family Asthma Management Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 DeVilbiss Healthcare Family Asthma Management Product Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 DeVilbiss Healthcare Recent Developments
11.4 Rossmax International Ltd.
11.4.1 Rossmax International Ltd. Corporation Information
11.4.2 Rossmax International Ltd. Overview
11.4.3 Rossmax International Ltd. Family Asthma Management Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Rossmax International Ltd. Family Asthma Management Product Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Rossmax International Ltd. Recent Developments
11.5 CareFusion
11.5.1 CareFusion Corporation Information
11.5.2 CareFusion Overview
11.5.3 CareFusion Family Asthma Management Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CareFusion Family Asthma Management Product Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CareFusion Recent Developments
11.6 Omron
11.6.1 Omron Corporation Information
11.6.2 Omron Overview
11.6.3 Omron Family Asthma Management Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Omron Family Asthma Management Product Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Omron Recent Developments
11.7 PARI
11.7.1 PARI Corporation Information
11.7.2 PARI Overview
11.7.3 PARI Family Asthma Management Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 PARI Family Asthma Management Product Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 PARI Recent Developments
11.8 GF
11.8.1 GF Corporation Information
11.8.2 GF Overview
11.8.3 GF Family Asthma Management Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 GF Family Asthma Management Product Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GF Recent Developments
11.9 Allied Healthcare Products
11.9.1 Allied Healthcare Products Corporation Information
11.9.2 Allied Healthcare Products Overview
11.9.3 Allied Healthcare Products Family Asthma Management Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Allied Healthcare Products Family Asthma Management Product Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Allied Healthcare Products Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Family Asthma Management Product Industry Chain Analysis
12.2 Family Asthma Management Product Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Family Asthma Management Product Production Mode & Process
12.4 Family Asthma Management Product Sales and Marketing
12.4.1 Family Asthma Management Product Sales Channels
12.4.2 Family Asthma Management Product Distributors
12.5 Family Asthma Management Product Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Family Asthma Management Product Industry Trends
13.2 Family Asthma Management Product Market Drivers
13.3 Family Asthma Management Product Market Challenges
13.4 Family Asthma Management Product Market Restraints
14 Key Findings in The Global Family Asthma Management Product Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer